Literature DB >> 15189173

Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid.

Sangho Lee1, Taewon Lee, Byungcheol Lee, Hyuckjai Choi, Munho Yang, Chun-Gyoo Ihm, Myungjae Kim.   

Abstract

Chinese herb nephropathy contains a variety of clinical features of progressive renal failure (indicated by studies conducted in Belgium) to the variant type of Fanconi's syndrome. Fanconi's syndrome has mostly been reported in Asian countries, and is characterized by proximal tubular dysfunction and slower progression to end-stage renal disease (ESRD); it also often revealed a reversible clinical course. We describe a 43-year-old woman who presented with polyuria and polydipsia caused by Fanconi's syndrome. The cause of Fanconi's syndrome was not identified because the patient denied the intake of the Chinese herbal mixture at first. Fanconi's syndrome seemed to be reversible in its early stage, but it rapidly progressed to renal failure after 3 months, despite the interruption of Chinese mixture use. A renal biopsy revealed typical findings of aristolochic acid-induced nephropathy. Aristolochic acids were also detected in the Chinese herbs that were consumed. This case highlights the variety of the clinical spectrum of aristolochic acid induced nephropathy (AAN). We emphasize that AAN should be suspected in all patients with Fanconi's syndrome, even if patients deny the intake of any Chinese herbal preparation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15189173     DOI: 10.1111/j.1440-1797.2003.00232.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  13 in total

1.  An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database).

Authors:  Shao-Ke Lou; Ka-Lok Wong; Ming Li; Paul Pui-Hay But; Stephen Kwok-Wing Tsui; Pang-Chui Shaw
Journal:  BMC Genomics       Date:  2010-06-24       Impact factor: 3.969

Review 2.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

Review 3.  Phytochemical analysis of medicinal plants with kidney protective activities.

Authors:  Eric Jung-Chi Lien; Linda Lin-Min Lien; Rubin Wang; Jeffrey Wang
Journal:  Chin J Integr Med       Date:  2011-04-26       Impact factor: 1.978

Review 4.  Aristolochic acid-associated cancers: a public health risk in need of global action.

Authors:  Samrat Das; Shefali Thakur; Michael Korenjak; Viktoriya S Sidorenko; Felicia Fei-Lei Chung; Jiri Zavadil
Journal:  Nat Rev Cancer       Date:  2022-07-19       Impact factor: 69.800

Review 5.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

6.  Patent applications for using DNA technologies to authenticate medicinal herbal material.

Authors:  Pang-Chui Shaw; Ka-Lok Wong; Albert Wai-Kit Chan; Wai-Cheong Wong; Paul Pui-Hay But
Journal:  Chin Med       Date:  2009-11-24       Impact factor: 5.455

Review 7.  Non-drug-induced nephrotoxicity.

Authors:  Justine Bacchetta; Laurence Dubourg; Laurent Juillard; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2009-04-28       Impact factor: 3.714

8.  Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs.

Authors:  Yin-Tai Hong; Lin-Shien Fu; Lin-Huei Chung; Shien-Chung Hung; Yi-Ting Huang; Chin-Shiang Chi
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

Review 9.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

10.  An authenticity survey of herbal medicines from markets in China using DNA barcoding.

Authors:  Jianping Han; Xiaohui Pang; Baosheng Liao; Hui Yao; Jingyuan Song; Shilin Chen
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.